-
VieCure announced a strategic partnership with Guardant Health to embed Guardant’s next-generation sequencing-based precision oncology tests into the VieCure Halo Intelligence platform.
Jul 9, 2025
-
I wanted to share a story that may be of interest to 360Dx: our startup OraLiva has just received a $1.9 million NIH/NIDCR Direct to Phase II SBIR grant to advance our AI-driven cancer diagnostic platform for the early detection of oral potentially malignant disorders (OPMDs) using non-invasive brush biopsy samples.
The platform, called Onc In-Cyt, is designed to bring scalable, low-cost cancer diagnostics into the dental office by combining point-of-care collection with CLIA lab–based AI cytology analysis. It aims to reduce the cost, delay, and subjectivity of traditional pathology workflows — addressing a major diagnostic blind spot where millions of Americans present annually with lesions that may harbor early-stage cancer. The grant will also accelerate the company’s timeline toward a regulated, widely distributed point-of-care diagnostic device for a series of epithelial cancers (e.g., bladder, cervical, anal, esophageal).
The NIH funding will support clinical validation and development of a regulated point-of-care device. You can find the NIH project summary here:
https://reporter.nih.gov/search/YKKJhXympkGvSd1LJ2GC0g/project-details/10921587#description
I’d be happy to share our press release or set up an interview with our team. Let me know if this could be a fit.
Jul 9, 2025
-
ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced that it has received UK Conformity Assessed (UKCA) marking for its Avantect® Pancreatic Cancer Test. The UKCA mark, established as part of the United Kingdom’s independent product safety regulatory framework following its departure from the European Union, signifies compliance with UK medical device regulations and paves the way for commercial availability in the UK market.
Jul 8, 2025
-
Leinco Technologies has acquired BioClin, Inc.'s essential IVD raw material antibody clones, significantly expanding its catalog, particularly for endocrine hormone research and diagnostic assays. This strategic acquisition enhances Leinco's commitment to providing high-quality, USA-based IVD raw materials to diagnostic manufacturers globally.
Jul 6, 2025
-
Creative Diagnostics releases its new Human Hybrid IgM Control Monoclonal Antibodies for research applications.
Jul 2, 2025
-
PHARMASEAL, provider of the Engility® Trial Management Platform consisting of a Clinical Trial Management System (CTMS) CTMS and Electronic Trial Master File (eTMF), has announced a Technology Integration Partnership with Viedoc, a global leader in Electronic Data Capture (EDC) and eClinical technologies. This collaboration integrates PHARMASEAL’s advanced CTMS platform with Viedoc’s cutting-edge EDC capabilities, including its flagship product Viedoc Clinic, to deliver a more integrated solution for life science companies managing clinical trials worldwide.
Jul 1, 2025
-
Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL to expand access to high-quality bioanalysis products.
Jun 30, 2025
-
Baylor Genetics, a leading clinical diagnostic laboratory at the forefront of genetic testing, today announced its support for the American Academy of Pediatrics’ (AAP) updated guidance recommending whole genome and whole exome sequencing as first-tier tests. Baylor Genetics has long recognized the value of these tests, and offers a comprehensive, structured framework to help pediatricians promptly identify potential genetic causes in children presenting with global developmental delay (GDD) or intellectual disability (ID). This milestone empowers pediatricians, supported by genetics professionals, with access to earlier and more comprehensive insights that guide clinical decisions for patients and their families, marking a critical step toward faster diagnoses and improved outcomes.
Jun 25, 2025
-
Alithea Genomics has announced the commercial launch of MERCURIUS™ FLASH-seq, a next-generation library preparation kit for full-length single-cell RNA sequencing.
Jun 25, 2025
-
AMP recently published a new report with 12 best practice recommendations focused on the design and validation of clinical HRD assays. To develop these recommendations, AMP assembled an expert panel that included organizational representation from ACCC, ASCO, and the CAP.
Jun 23, 2025
-
Jun 23, 2025
-
Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), today announced the appointment of Billy Amzal as Head of Strategic Consulting.
Jun 23, 2025
-
To make it easier for researchers to find and access the specialized chemicals they need, Alfa Chemistry has announced that it has been added as a supplier to the CHEMnetBASE dictionaries, the world’s premier collection of interactive chemistry databases from CRC Press, Taylor & Francis Group. This means that Alfa Chemistry’s vast catalog of specialized chemicals will be easily discoverable within the premier digital chemistry resource used by researchers and scientists around the world.
Jun 24, 2025
-
Alithea Genomics has announced the launch of MERCURIUS™ Total DRUG-seq to push the boundaries of high-throughput drug screens, toxicology screens and target validation.
Jun 18, 2025
-
PackworldUSA highlights the launch of its advanced 3400 Series Heat Sealer, designed specifically for industries requiring high-precision packaging solutions. For medical applications, this system offers unmatched versatility, cleanroom compatibility, and ease of use.
Jun 17, 2025
-
One2Treat SA, a fast-growing tech company incorporating the patient voice in all strategic decisions about treatment assessments in Pharma R&D, today announced the launch of the One2Treat Voice app, a new module of their software platform.
Jun 16, 2025
-
Key appointment to lead the company’s financial strategy and support continued global growth in sample stability and biorepository storage solutions
Jun 16, 2025
-
ClearNote Health announced initiation of patient enrollment for a new study that aims to advance early detection of pancreatic cancer in individuals newly diagnosed with type 2 diabetes.
Jun 15, 2025
-
Survey of 360 senior professionals finds modernization is key to overcoming longstanding industry challenges.
Jun 10, 2025
-
Echosens and Boehringer Ingelheim have expanded their long-standing partnership to accelerate progress in MASH diagnosis and care.
Jun 9, 2025